---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295964461.md"
description: "Sagimet Biosciences shares are trading higher after Citizens raised its price target on the stock from $12 to $29."
datetime: "2026-08-14T18:11:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295964461.md)
  - [en](https://longbridge.com/en/news/295964461.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295964461.md)
generator: "portal-rs"
---

# 

Sagimet Biosciences shares are trading higher after Citizens raised its price target on the stock from $12 to $29.

### Related Stocks

- [SGMT.US](https://longbridge.com/en/quote/SGMT.US.md)
- [CFG.US](https://longbridge.com/en/quote/CFG.US.md)
- [CFG-I.US](https://longbridge.com/en/quote/CFG-I.US.md)
- [CFG-E.US](https://longbridge.com/en/quote/CFG-E.US.md)
- [CFG-H.US](https://longbridge.com/en/quote/CFG-H.US.md)

## Related News & Research

- [Sagimet Biosciences grants 260,700 inducement stock options to new hires](https://longbridge.com/en/news/296143081.md)
- [Sagimet Biosciences Eyes U.S. Phase III Acne Study After Positive China Data](https://longbridge.com/en/news/296073364.md)
- [Sagimet Biosciences Gets FDA Clearance For Phase 3 Acne Study](https://longbridge.com/en/news/295789901.md)
- [Sagimet wins FDA IND clearance for Phase 3 denifanstat acne trial](https://longbridge.com/en/news/295786871.md)
- [Sagimet director George Kemble disposes of 20,206 common shares worth $201,160.97](https://longbridge.com/en/news/295721415.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**